Actinium Pharmaceuticals, Inc. (ATNM) stock

ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/3079% below fair value

$1.64+0.05 (+3.14%)

Close on Nov 13, 2026Market cap $51.56MP/E 4.6Yield –

Actinium Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2021 it was 21.3%.

Period	Period end	Value	Change (pts)
FY2021	Dec 31, 2021	21.3%	–

Parsed from the XBRL in Actinium Pharmaceuticals's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-30 reverse split on Aug 11, 2020
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ATNM.

Operating margin10617.8% · median -12448.3%

Net margin12564.4% · median -9807.3%

Advertisement
300 × 250

See a number that looks wrong?